Published in Korean J Ophthalmol on April 30, 2013
Keratoconus. Surv Ophthalmol (1998) 10.52
Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol (2003) 8.29
Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol (1984) 5.29
Prognostic factors for the progression of keratoconus. Ophthalmology (1994) 1.83
Intacs for the correction of keratoconus: two-year follow-up. J Cataract Refract Surg (2007) 1.66
Toric Implantable Collamer Lens for moderate to high myopic astigmatism. Ophthalmology (2007) 1.45
Management of keratoconus: current scenario. Br J Ophthalmol (2010) 1.41
Clinical management of keratoconus. A multicenter analysis. Ophthalmology (1990) 1.29
Penetrating keratoplasty for keratoconus. Cornea (2000) 1.21
Toric Implantable Collamer Lens for high myopic astigmatic Asian eyes. Ophthalmology (2009) 1.00
One-year follow-up of posterior chamber toric phakic intraocular lens implantation for moderate to high myopic astigmatism. Ophthalmology (2010) 0.98
Phakic toric Implantable Collamer Lens implantation for the correction of high myopic astigmatism in eyes with keratoconus. J Refract Surg (2008) 0.96
Comparison of 2 intrastromal corneal ring segment models in the management of keratoconus. J Cataract Refract Surg (2010) 0.95
INTACS for Keratoconus. Int Ophthalmol Clin (2010) 0.94
Astigmatic power calculations for intraocular lenses in the phakic and aphakic eye. J Refract Surg (2004) 0.93
Surgical treatment of keratoconus at the turn of the 20th century. J Refract Surg (2001) 0.91
Implantation of verisyse phakic intraocular lens to correct myopic refractive error after penetrating keratoplasty in pseudophakic eyes. Cornea (2006) 0.83
A retrospective comparison of efficacy and safety of 680 consecutive lasik treatments for high myopia performed with two generations of flying-spot excimer lasers. Acta Ophthalmol (2010) 0.82
The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells (2008) 1.77
Implementation of Consolidated HIS: Improving Quality and Efficiency of Healthcare. Healthc Inform Res (2010) 1.54
Eyelid Tattooing Induces Meibomian Gland Loss and Tear Film Instability. Cornea (2015) 1.40
Modified transscleral fixation using combined temporary haptic externalization and injector intraocular lens implantation. J Cataract Refract Surg (2010) 1.11
Seoul National University Bundang Hospital's Electronic System for Total Care. Healthc Inform Res (2012) 1.10
Transscleral fixation of a foldable intraocular lens in aphakic vitrectomized eyes. J Cataract Refract Surg (2003) 1.09
Combined surgery and sequential surgery comprising phacoemulsification, pars plana vitrectomy, and intraocular lens implantation: comparison of clinical outcomes. J Cataract Refract Surg (2002) 1.04
A case of retained graphite anterior chamber foreign body masquerading as stromal keratitis. Korean J Ophthalmol (2011) 1.00
Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population. Korean J Ophthalmol (2010) 1.00
Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci (2011) 1.00
Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea. Korean J Ophthalmol (2008) 0.98
Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Graefes Arch Clin Exp Ophthalmol (2013) 0.98
Intraocular lens power calculation using IOLMaster and various formulas in short eyes. Korean J Ophthalmol (2011) 0.97
Corneoscleral cyst treated with distilled water injection. Korean J Ophthalmol (2002) 0.95
A case of cataract surgery without pupillary device in the eye with iridoschisis. Korean J Ophthalmol (2008) 0.95
One-year outcome of argon laser photocoagulation of pinguecula. Cornea (2013) 0.95
Efficacy of pig-to-rhesus lamellar corneal xenotransplantation. Invest Ophthalmol Vis Sci (2011) 0.94
Corneal endothelial dysfunction associated with amantadine toxicity. Cornea (2008) 0.94
Protective effect of clusterin on oxidative stress-induced cell death of human corneal endothelial cells. Mol Vis (2009) 0.94
Processing porcine cornea for biomedical applications. Tissue Eng Part C Methods (2009) 0.94
Protective effect of uridine on cornea in a rabbit dry eye model. Invest Ophthalmol Vis Sci (2007) 0.94
Corneal wasp sting accompanied by optic neuropathy and retinopathy. Jpn J Ophthalmol (2011) 0.94
Clinical comparison of ciliary sulcus and pars plana locations for posterior chamber intraocular lens transscleral fixation. J Cataract Refract Surg (2011) 0.92
In situ intraocular suture techniques for pupilloplasty and suspension of a subluxated intraocular lens. Ophthalmic Surg Lasers Imaging (2010) 0.91
Cytokine secretion by human mesenchymal stem cells cocultured with damaged corneal epithelial cells. Cytokine (2009) 0.91
Cytotoxicity of voriconazole on cultured human corneal endothelial cells. Antimicrob Agents Chemother (2011) 0.90
The effect of pterygium surgery on contrast sensitivity and corneal topographic changes. Clin Ophthalmol (2010) 0.90
Preliminary effects of oral uridine on the ocular surface in dry eye patients. J Korean Med Sci (2009) 0.90
Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye. Korean J Ophthalmol (2007) 0.90
The effect of amantadine on corneal endothelium in subjects with Parkinson's disease. Ophthalmology (2010) 0.90
The effect of different suturing techniques on astigmatism after penetrating keratoplasty. J Korean Med Sci (2008) 0.89
Five-year results of corneal tattooing for cosmetic repair in disfigured eyes. Cornea (2011) 0.89
Objective measurement of distance visual acuity determined by computerized optokinetic nystagmus test. Invest Ophthalmol Vis Sci (2009) 0.89
Investigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in patients with dry eye syndrome. Korean J Ophthalmol (2011) 0.88
Effects of multicurve RGP contact lens use on topographic changes in keratoconus. Korean J Ophthalmol (2010) 0.88
Changes of ocular higher order aberration in on- and off-eye of rigid gas permeable contact lenses. Optom Vis Sci (2007) 0.87
Long-term visual outcomes of penetrating keratoplasty for Peters anomaly. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Optic neuritis in Asian children. J Pediatr Ophthalmol Strabismus (2002) 0.87
A case of corneal endothelial deterioration associated with retained Descemet's membrane after penetrating keratoplasty. Jpn J Ophthalmol (2009) 0.86
The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas. Curr Eye Res (2009) 0.85
Clinical outcome of penetrating keratoplasty in patients 5 years or younger: peters anomaly versus sclerocornea. Cornea (2013) 0.85
Primary sebaceous carcinoma of the corneaoscleral limbus with pagetoid recurrence. Korean J Ophthalmol (2009) 0.85
Oral alcohol administration disturbs tear film and ocular surface. Ophthalmology (2012) 0.85
Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy. Cornea (2009) 0.85
Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis. Cornea (2007) 0.84
Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. Invest Ophthalmol Vis Sci (2013) 0.84